64 unknown, 63 completed, 41 recruiting, 30 terminated. 260 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 260 | Unknown 64, Completed 63, Recruiting 41, Terminated 30, Not yet recruiting 23, Withdrawn 17, Active not recruiting 14, Enrolling by invitation 5, Suspended 3 |
Follow Digestive System Neoplasms: new trials by email Literature Review of Digestive System Neoplasms trials Research Report on Digestive System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NK521 in the Treatment of Advanced Solid Tumors NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer | Early Phase 1 | Not yet recruiting | Base Therapeutics (Shanghai) Co., Ltd. | 18 | 2027-01-01 | 2026-09-30 |
| Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study ICI Therapy - Gastrointestinal Neoplasms, Genitourinary Cancer | Early Phase 1 | Not yet recruiting | Indiana University | 80 | 2027-01-01 | 2026-11-18 |
| GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer GLP1-RA (semaglutide) - Pancreatic Cancer, Colorectal Cancer | Early Phase 1 | Recruiting | University of Arizona | 30 | 2026-10-07 | 2026-11-16 |
| Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer CBG131 CAR-T Cell Infusion - Advanced Gastric and Pancreatic Cancer | Early Phase 1 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 18 | 2026-09-30 | 2026-02-06 |
| THIO and Cadonilimab in Resectable Hepatocellular Carcinoma ateganosine, Cadonilimab - Resectable Hepatocellular Carcinoma | Early Phase 1 | Recruiting | University of Texas Southwestern Medical Center | 60 | 2026-09-01 | 2026-09-03 |
| Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer [64Cu]CM500, [68Ga]CM500, PET/MR - Bladder Cancer, Glioma | Early Phase 1 | Not yet recruiting | Lumina Pharmaceuticals Inc | 40 | 2026-09-01 | 2026-08-28 |
| Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection Autologous Cytokine-Induced Killer (CIK) Cells - Hepatocellular Carcinoma (HCC) | Early Phase 1 | Not yet recruiting | Royan Institute | 6 | 2026-07-01 | 2026-07-16 |
| Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors [⁶⁸Ga]Ga-HT547 and [¹⁷⁷Lu]Lu-HT547 - Breast Cancer, Head and Neck Cancer (H&N) | Early Phase 1 | Not yet recruiting | Hua Pang | 20 | 2026-06-01 | 2026-06-10 |
| A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer [68Ga]/ [131I]-IR199 - Gastric Cancer, Pancreatic Cancer | Early Phase 1 | Recruiting | Huashan Hospital | 10 | 2026-06-01 | 2026-07-16 |
| A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer ES502 Injection - Pancreatic Cancer | Early Phase 1 | Recruiting | Ruijin Hospital | 24 | 2026-05-18 | 2026-06-16 |
| Botensilimab, Balstilimab, and SBRT in Colorectal Cancer Stereotactic Body Radiation Therapy (SBRT), Botensilimab, Balstilimab - Non-MSI-H or pMMR Colorectal Cancer With Liver Metastasis | Early Phase 1 | Recruiting | Massachusetts General Hospital | 15 | 2026-05-12 | 2026-05-13 |
| A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33 GPA33-CC;177Lu-SmartD2 - Colorectal Cancer | Early Phase 1 | Not yet recruiting | SmartNuclide Biopharma | 20 | 2026-05-01 | 2026-05-15 |
| ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer SOC (Standard of care), Bevacizumab, Cetuximab - Dynamic Tumor Resistance, Metastatic Colorectal Cancer | Early Phase 1 | Recruiting | M.D. Anderson Cancer Center | 100 | 2026-04-22 | 2026-10-14 |
| Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy [68Ga]Ga-ABY-025 - Locally Advanced Cancer, Metastatic Cancer | Early Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 30 | 2026-04-16 | 2026-05-08 |
| Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection Peginterferon alfa-2b, TDF, TAF - Hepatocellular Carcinoma, HEPATITIS B CHRONIC | Early Phase 1 | Not yet recruiting | Ningbo No.2 Hospital | 156 | 2026-03-31 | 2026-04-28 |
| Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma Metabolically Armed GPC3 CAR-T cells - Hepatocellular Carcinoma (HCC) | Early Phase 1 | Not yet recruiting | Zhejiang University | 27 | 2026-03-30 | 2026-04-21 |
| An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. KT032(anti-MSLN chimeric antigen receptor autologous T cell injection) - Ovarian Cancer, Mesothelioma | Early Phase 1 | Not yet recruiting | Weijia Fang, MD | 24 | 2026-03-15 | 2026-02-19 |
| B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. blood plasma sample, blood sampling - Breast Cancer, Pancreatic Cancer | Early Phase 1 | Recruiting | Poitiers University Hospital | 220 | 2026-02-03 | 2026-02-05 |
| COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + Nivolumab - Colorectal Cancer Metastatic, Colorectal Cancer Stage III | Early Phase 1 | Recruiting | Biogenea Pharmaceuticals Ltd. | 12 | 2026-02-02 | 2026-01-09 |
| Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma 68Ga-XH06 - Malignant Neoplasm of Liver | Early Phase 1 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 150 | 2026-01-30 | 2026-01-20 |
Showing 20 of 260. Sign in to see all of them.
Pancreatic Neoplasms (81) · Colorectal Neoplasms (56) · Carcinoma, Hepatocellular (53) · Stomach Neoplasms (36) · Colonic Neoplasms (26) · Breast Neoplasms (25) · Lung Neoplasms (16) · Ovarian Neoplasms (15) · Liver Neoplasms (13) · Rectal Neoplasms (12) · Esophageal Neoplasms (11) · Gastrointestinal Neoplasms (11) · Neoplasms (11) · Sarcoma (11) · Carcinoma, Non-Small-Cell Lung (8)
Digestive System Diseases (260) · Neoplasms by Site (258) · Neoplasms (249) · Gastrointestinal Diseases (134) · Gastrointestinal Neoplasms (123) · Endocrine Gland Neoplasms (94) · Endocrine System Diseases (94) · Intestinal Diseases (88) · Intestinal Neoplasms (88) · Neoplasms by Histologic Type (88) · Pancreatic Diseases (86) · Colonic Diseases (83) · Neoplasms, Glandular and Epithelial (80) · Carcinoma (66)
Magnetic Resonance Spectroscopy (11) · Fluorouracil (8) · Oxaliplatin (8) · Biopsy (6) · Gemcitabine (6) · Irinotecan (6) · Leucovorin (6) · Bevacizumab (5) · Nivolumab (5) · Radiosurgery (5) · Capecitabine (4) · Oncolytic Virotherapy (4) · Radiation (4) · Specimen Handling (4) · lenvatinib (4)
Peking Union Medical College Hospital (6) · Beijing Ditan Hospital (5) · Massachusetts General Hospital (5) · Mayo Clinic (5) · OHSU Knight Cancer Institute (5) · Ruijin Hospital (5) · Shanghai Yunying Medical Technology (5) · BioSyngen Pte Ltd (4) · Case Comprehensive Cancer Center (4) · H. Lee Moffitt Cancer Center and Research Institute (4) · M.D. Anderson Cancer Center (4) · National Cancer Institute (NCI) (4) · Shanghai Changzheng Hospital (4) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (4) · Base Therapeutics (Shanghai) Co., Ltd. (3)
United States (107) · China (92) · France (4) · Netherlands (3) · Taiwan (3) · United Kingdom (3) · Canada (2) · Egypt (2) · Spain (2) · Belgium (1) · Greece (1) · India (1) · Iran (1) · Iraq (1) · Ireland (1)
Alexander Guimaraes (2) · Baiyong Shen (2) · Charles D Lopez (2) · Mingyong Han, PhD (2) · Mingyu Sun, doctor (2) · Scott Irwin, MD, PhD (2) · Wei-Fen Xie, M.D. (2) · Yuqing Li, PhD (2) · Zhaohui Zhu (2) · Aaron J Scott, MD (1) · Aaron Weitzman, MD (1) · Adam H Buchanan, MS, MPH, CGC (1) · Ahmed E Mohamed, Master (1) · Ajay Jain, MD (1) · Ajit H Goenka, MD (1)
PMID 17197840, PMID 17701250, PMID 19095497, PMID 20518581, PMID 22321518, PMID 23340005, PMID 24493717, PMID 24614108, PMID 24696183, PMID 25027973, PMID 25209657, PMID 25691612, PMID 26674592, PMID 27275632, PMID 27918777, PMID 29471013, PMID 30207593, PMID 30220234, PMID 30959462, PMID 31063184, PMID 31070690, PMID 31579027, PMID 31592772, PMID 31858837, PMID 32414353, PMID 32497895, PMID 33365268, PMID 33538338, PMID 34376577, PMID 34729628, PMID 35303929, PMID 35660135, PMID 35708168, PMID 36512649, PMID 36748942, PMID 36990609, PMID 37344887, PMID 38325328, PMID 38926162, PMID 38970713, PMID 39448271, PMID 39499011, PMID 40115982, PMID 40135850, PMID 40914168, PMID 41101974, PMID 41193187, PMID 41556358, PMID 41688850, PMID 41878443
P30CA033572 (2), P30CA068485 (2), K01DK120742 (1), P30CA006973 (1), P30CA014089 (1), P30CA043703 (1), P30CA046934 (1), P30CA060553 (1), P30CA072720 (1), P30CA093373 (1), P30CA124435 (1), P30CA138292 (1), P50CA127003 (1), R01CA154982 (1), R01CA243014 (1)